12:00 AM
 | 
Mar 26, 2012
 |  BC Week In Review  |  Clinical News  |  Regulatory

Astepro azelastine HCL 0 regulatory update

Meda said Astepro azelastine was approved in Europe under the decentralized procedure to treat allergic rhinitis. The company...

Read the full 69 word article

User Sign in

Trial Subscription

Get a 4-week free trial subscription to BioCentury Week In Review

Article Purchase

$30 USD
More Info >